Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (190)
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
77,850
Price
$4.96
Total Value
$385.79K
Shares Held After
686,116
% of Holdings
11.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
100,000
Price
$4.90
Total Value
$490.00K
Shares Held After
608,266
% of Holdings
16.4%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$4.81
Total Value
$120.34K
Shares Held After
508,266
% of Holdings
4.9%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
20,000
Price
$5.00
Total Value
$100.00K
Shares Held After
483,266
% of Holdings
4.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
20,000
Price
$5.00
Total Value
$100.00K
Shares Held After
463,266
% of Holdings
4.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
50,000
Price
$4.97
Total Value
$248.62K
Shares Held After
443,266
% of Holdings
11.3%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
26,291
Price
$0.18
Total Value
$4.81K
Shares Held After
26,291
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,044
Price
$323.69
Total Value
$337.93K
Shares Held After
0
% of Holdings
100.0%
SHOULDER INNOVATIONS, INC. (SI)
Gilde Healthcare Holding B.V. — 10% Owner
Shares
28,245
Price
$23.36
Total Value
$659.80K
Shares Held After
2,352,237
% of Holdings
1.2%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
114,756
Price
$6.93
Total Value
$795.26K
Shares Held After
2,848,310
% of Holdings
3.9%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
114,756
Price
$6.93
Total Value
$795.26K
Shares Held After
2,848,310
% of Holdings
3.9%
ILLUMINA, INC. (ILMN)
Davies Scott M — Chief Legal Officer
Shares
615
Price
$200.00
Total Value
$123.00K
Shares Held After
20,338
% of Holdings
2.9%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
2,000
Price
$80.06
Total Value
$160.12K
Shares Held After
127,401
% of Holdings
1.5%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
1,001
Price
$120.67
Total Value
$120.80K
Shares Held After
16,130
% of Holdings
5.8%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,103
Price
$119.95
Total Value
$971.94K
Shares Held After
17,131
% of Holdings
32.1%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,783
Price
$118.73
Total Value
$567.91K
Shares Held After
25,234
% of Holdings
15.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,267
Price
$117.93
Total Value
$974.95K
Shares Held After
30,017
% of Holdings
21.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
7,089
Price
$116.96
Total Value
$829.10K
Shares Held After
38,284
% of Holdings
15.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
14,222
Price
$115.87
Total Value
$1.65M
Shares Held After
45,373
% of Holdings
23.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
15,477
Price
$114.96
Total Value
$1.78M
Shares Held After
59,595
% of Holdings
20.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,700
Price
$113.18
Total Value
$531.94K
Shares Held After
75,072
% of Holdings
5.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
600
Price
$110.95
Total Value
$66.57K
Shares Held After
79,772
% of Holdings
0.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
2,202
Price
$110.03
Total Value
$242.28K
Shares Held After
80,372
% of Holdings
2.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
400
Price
$108.46
Total Value
$43.38K
Shares Held After
82,574
% of Holdings
0.5%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,956
Price
$106.96
Total Value
$957.89K
Shares Held After
82,974
% of Holdings
9.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,200
Price
$105.54
Total Value
$443.25K
Shares Held After
91,930
% of Holdings
4.4%
Jushi Holdings Inc. (JUSH)
Barack Louis Jon — President
Shares
5,600
Price
$0.41
Total Value
$2.30K
Shares Held After
2,857,373
% of Holdings
0.2%
Jushi Holdings Inc. (JUSH)
Barack Louis Jon — President
Shares
10,000
Price
$0.40
Total Value
$4.00K
Shares Held After
2,851,773
% of Holdings
0.4%
Jushi Holdings Inc. (JUSH)
Barack Louis Jon — President
Shares
20,000
Price
$0.39
Total Value
$7.80K
Shares Held After
2,841,773
% of Holdings
0.7%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
28
Price
$346.83
Total Value
$9.71K
Shares Held After
1,294
% of Holdings
2.1%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Shares
50
Price
$26.17
Total Value
$1.31K
Shares Held After
18,994
% of Holdings
0.3%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Shares
16,508
Price
$26.13
Total Value
$431.35K
Shares Held After
19,044
% of Holdings
46.4%
IONIS PHARMACEUTICALS INC (IONS)
Hayden Michael R — Director
Shares
15,000
Price
$53.38
Total Value
$800.70K
Shares Held After
19,000
% of Holdings
78.9%
ANGIODYNAMICS INC (ANGO)
Nighan Warren JR — SVP Quality and Regulatory
Shares
23,370
Price
$14.72
Total Value
$344.01K
Shares Held After
64,745
% of Holdings
26.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$528.96
Total Value
$21.16K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$526.92
Total Value
$210.77K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,084
Price
$525.80
Total Value
$1.10M
Shares Held After
324,883
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,846
Price
$524.88
Total Value
$2.54M
Shares Held After
326,967
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,486
Price
$523.87
Total Value
$778.48K
Shares Held After
331,813
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
644
Price
$523.04
Total Value
$336.84K
Shares Held After
333,299
% of Holdings
0.2%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
500
Price
$48.90
Total Value
$24.45K
Shares Held After
1,078
% of Holdings
31.7%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
2,500
Price
$48.90
Total Value
$122.25K
Shares Held After
1,078
% of Holdings
69.9%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
1,500
Price
$48.90
Total Value
$73.35K
Shares Held After
1,078
% of Holdings
58.2%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
558,633
Price
$8.20
Total Value
$4.58M
Shares Held After
6,633,314
% of Holdings
7.8%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
1,000,000
Price
$13.00
Total Value
$13.00M
Shares Held After
20,906,689
% of Holdings
4.8%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
121,338
% of Holdings
3.1%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,845
Price
$23.38
Total Value
$66.52K
Shares Held After
44,927
% of Holdings
6.0%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
19,912
% of Holdings
16.2%
Edwards Lifesciences Corp (EW)
Markowitz Wayne — CVP, JAPAC
Shares
146
Price
$86.03
Total Value
$12.59K
Shares Held After
21,534
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
14,000
Price
$79.88
Total Value
$1.12M
Shares Held After
58,555
% of Holdings
19.3%
Showing 51–100 of 190 transactions (page 2 of 4)